Mushrooms and Madness: Hallucinogenic Mushrooms and Some Psychopharmacological Implications

Axelrod J. : Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science, 134: 343, 1961.

Brune G.G. , Himwich H.E. : “Biogenic Amines and Behaviour in Schizophrenic Patients”, in Recent Advances in Biological Psychiatry, Wortis J. (ed) New York: Plenum Press, 144–160, 1963.

Cottrell A.C. , McLeod M.F. , McLeod W.R. : A bufotenine-like substance in the urine of schizophrenics. Am J Psychiatry, 134: 322–323, 1977.

DeJong H.H. : Experimental Catatonia. Baltimore: Williams and Wilkins, 1945.

Domino E.F. : “The Indole Hallucinogen Model: Is it Worth Pursuing?” in Predictability in Psychopharmacology; Preclinical and Subclinical Correlations. Sudilovsky A. , Gershon S. , and Beer B. (eds). New York: Raven Press, 1975.

Eugster C.H. : “Isolation, Structures and Syntheses of Central-Active Compounds from Amanita muscaria (L. ex Fr.) Hooker” in Ethnopharmacologic Search for Psychoactive Drugs. Efron D.H. (ed). Washington, D.C.: Public Health Service Publication #1645, 416–418, 1967.

Fabing H.D. , Hawkins J.R. : Intravenous bufotenine injection in the human being. Science, 123: 886–887, 1956.

Friedhoff A.J. : “Biosynthesis of Endogenous Hallucinogens” in Neuroregulators and Psychiatric Disorders. Usdin E. , Hamburg D. , and Barchas J. (eds). New York: Oxford University Press, 1977, pp. 557–64.

Gillin J.C. , Kaplan J. , Stillman R. , Wyatt R.J. : The psychedelic model of schizophrenia: The case of N, N-dimethyltryptamine. Am J Psychiatry, 133: 203–208, 1976.

Guzman G. , Vergeer P. : Index of taxa in the genus psilocybe. Mycotaxon, 6: 464–476, 1978.

Haard R. , Haard K. : Poisonous and Hallucinogenic Mushrooms. Seattle: Cloudburst Press, 1975.

Heller B. , Karashimhachari N. , Spaide J. , Haskovec L. , Himwich H.E. : N-dimethylated tryptamines in the blood of acute schizophrenics. Experientia, 26: 503–504, 1970.

Heller B. : N-methylating enzymes in the blood of schizophrenics. Psychosomatics, 12: 273–274, 1971.

Himwich H.E. , Narasimhachari N. , Heller B. ,: “Comparative Behavioural and Urinary Studies on Schizophrenics and Normal Controls” in Biochemistry of Brain and Behaviour. Bowman R. , and Surinder P.D. (eds). New York: Plenum Press, 1970.

Hoffer A. , Osmond H. : The Hallucinogens. New York: Academic Press, 1967.

Hollister L.E. : Chemical Psychoses: LSD and Related Drugs. Springfield, Illinois: Charles C. Thomas, 1968.

Koslow S.H. : “Biosignificance of N- and O-Methylated Indoles to Psychiatric Disorders” in Neuroregulators and Psychiatric Disorders. Usdin E. , Hamburg D.A. , and Barchas J.D. (eds). New York: Oxford University Press, 1977, pp. 210–219.

Leung A.Y. , Paul A.G. : Baeocystin and norbaeocystin: New analogs of psilocybin from psilocybe Baeocystis. J Pharm Sci, 57: 1667–1671, 1968.

Lloyd K.G. , Bartholini G. : “The Effects of Methothiopen on Cerebral Monoamine Neurons” in Advances in Biochemical Pharmacology. 10, Costa E. , Gessa G.L. , and Sandler M. (eds). New York: Raven Press, 1974.

Matthysse S. , Baldessarini R.J. : Sadenosylmethionine and Catechol-o-methyltransferase in schizophrenia. Am J Psychiatry, 128: 130–132, 1970.

McDonald A. : “The Present Status of Soma: The Effects of California Amanita muscaria on Normal Volunteers” in Mushroom Poisonings. Rumack B. , and Salzman E. (eds) West Palm Beach, Florida: CRC Press, 1978.

Morgan M. , Mandell A.J. : Indole (ethyl) amine N-methyl-transferase in the brain. Science, 165: 492–493, 1969.

Narasimhachari N. , Lin R.L. : “A possible mechanism for the antischizophrenic action of chlorpromazine: Inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites”. Research Communications in the Chemistry of Pathology and Pharmacology, 1974.

Nies A. , Robinson D.S. , Lamborn K.R. , Lampert R.P. : Genetic control of platelet and plasma onoamine oxidase activity. Arch Gen Psychiatry, 28: 834–838, 1973.

Ott J. , Guzman G. , Romano M. , and Diaz J.L. : “Nuevos datos sobre supuestos licopendaceos posicotropico y doc. Casos de intoxicacion proprocados por honogos del generao Scleroderma en Mexico. Boletin de la Sociedad Mexicana de Micologia, No. 9, 1975, p. 67–76.

Price J.M. , Brown R.R. , Peters H.A. : Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurological and psychiatric diseases. Neurology, 9: 456–468, 1959.

Reko B.P. : Mexico Antiguo, De los nombres botanicos aztecos, 1: 113–157, 1919.

Rodnight R. : Body fluid indoles in mental illness. Int Rev Neurobiology 3: 251–291, 1961.

Rosengarten H. , Piotrowski A. , Romeszewska K. , Szemis A. , Jus A. : The occurence of N, N-dimethyltryptamine and bufotenine in schizophrenic patients without MAO blockage and methionine loading. Proc 7th Collegium Internationale Neuropsychopharmacologicum Congress, Prague, 2, 1970, p. 367.

Safford W.E. : An Aztec narcotic. J Hered, 6: 291–311, 1915.

Schultes , Richard E. : “An Overview of Hallucinogens in the Western Hemisphere” in Flesh of the Gods, Furst Peter T. , (ed) New York: Praeger Publishers, 1972, p. 9.

Schwartz M.A. , Aikens A.M. , Wyatt R.J. : Monoamine oxidase activity in brains from schizophrenic and mentally normal individuals. Psychopharmacologia, 38: 319–328, 1974.

Szara S. : “Hallucinogenic Amines and Schizophrenia” in Amines and Schizophrenia. Himwich H.E. , Kety S.S. , and Smithies J.R. (eds). Oxford: Pergamon Press, 1967, pp. 181–197.

Waser P.G. : “The Pharmacology of Amanita muscaria” in Ethnopharmacologic Search for Psychoactive Drugs. Efron D.H. , (ed) Public Health Service Publication #1645, Washington, D.C., 1967, pp. 419–439.

Wasson R.G. : Soma: Divine Mushroom of Immortality. New York: Harcourt Brace & World, 1968.

Wasson V.P. , Wasson R.G. : Russia, Mushrooms and History. New York: Pantheon Books, 1957.

Wyatt R.J. , Saavedra J.M. , Belmaker R. , Cohen S. , Pollin W. : The dimethyltryptamine forming enzyme in blood platelets: A study of monozygotic twins discordant for schizophrenia. Am J Psychiatry, 130: 1359–1361, 1973.